Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
about
Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathyRecipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on OsteopeniaAMP-activated protein kinase regulates beta-catenin transcription via histone deacetylase 5.In Vitro and In Vivo Effects of Metformin on Osteopontin Expression in Mice Adipose-Derived Multipotent Stromal Cells and Adipose Tissue5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiationMice lacking AMP-activated protein kinase α1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment.IGF-I and IGFBP-2 Stimulate AMPK Activation and Autophagy, Which Are Required for Osteoblast DifferentiationAMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone massGenetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice.Metformin Decreases Reactive Oxygen Species, Enhances Osteogenic Properties of Adipose-Derived Multipotent Mesenchymal Stem Cells In Vitro, and Increases Bone Density In VivoThe anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.Functional differences between AMPK α1 and α2 subunits in osteogenesis, osteoblast-associated induction of osteoclastogenesis, and adipogenesis.Adult Stem Cells and Diseases of Aging.Transcriptomes and proteomes of dental follicle cells.Diabetes medications and bone.Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review.Diabetes Drug Effects on the Skeleton.Fibroblast growth factor-7 facilitates osteogenic differentiation of embryonic stem cells through the activation of ERK/Runx2 signaling.Periodontal fibroblasts modulate proliferation and osteogenic differentiation of embryonic stem cells through production of fibroblast growth factors.Bone Cell Bioenergetics and Skeletal Energy Homeostasis.Effects of Bioactive Compounds on Odontogenic Differentiation and Mineralization.Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitisCorrelates of fractures in elderly, diabetic outpatients.Review article: effects of type 2 diabetes therapies on bone metabolism.Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase.Effects of a self-assembling peptide as a scaffold on bone formation in a defect.AMPK downregulates ALK2 via increasing the interaction between Smurf1 and Smad6, leading to inhibition of osteogenic differentiation.Effect of metformin on ossification and inflammation of fibroblasts in ankylosing spondylitis: An in vitro study.Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women.(-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption.Effects of metformin on bone healing around titanium implants inserted in non-diabetic rats.Metformin and Autoimmunity: A "New Deal" of an Old Drug.
P2860
Q26750278-21562ED1-58E5-4BE6-AC62-6B99A8605562Q33588206-56D253E2-2D1A-4DFA-9710-8F5BF8DC3592Q34963731-0DF5DF85-02A7-4C58-828C-1A30E7F7EF5CQ35603472-EBD05EEA-26CC-4D5D-B695-99184022ECEBQ35950107-A3C350F9-A847-40B7-A866-46B813D73AD6Q36189054-CEFEF3A2-CA1A-497E-AD7F-69F5E8B14036Q36431813-E5B9A205-17BA-4185-9383-7F45E06CD026Q36776165-DE5022A7-A7C8-4911-9CD5-7B2F7F62D325Q36796911-FD9DF548-840E-4D8F-9FBB-D3AA34B7873FQ36855499-7E1A9F2F-94EF-4543-BFD8-19DD49A4F983Q37182800-AA99FC41-B4B2-4A74-BD8A-99960A094559Q37236654-E4913013-3948-4B04-9AAF-016CD725A6C9Q37711264-FDCE0071-2720-4F35-AF88-E1BB3CC5E21EQ37720328-910D3210-C39E-4D85-80D6-964BE704AF98Q38272637-89ACF8A2-AEDC-43CC-AFF4-0E331736CAC7Q38441017-AB3E1E3E-46B6-466E-AF97-A4E484AB787BQ38999214-9F7FA058-17F5-44CD-939F-611CC5143D01Q39096975-46A9E90C-06E5-422A-B059-1C6C4FD2F92FQ39134292-8CC24121-BFBD-47BA-916A-38D30554D061Q39137277-507CF101-4418-49A0-9078-B6C542F8F0EDQ40403277-62D5B832-B0D3-4935-9AE6-B975B1FB7CACQ41536841-09C8B814-C3FB-4B27-AF58-21B6598D9550Q41733322-6270065F-BC59-4A61-A750-93406755C81EQ42363966-AFEE8C71-7DAF-4ACC-BE8E-6DC7CCE75E3EQ43925968-72FE26B6-7800-4F5C-8240-C5CC8E3E9C23Q47557479-2E2EF462-3895-4006-B91B-2DC2A8FF832EQ47895489-BB333407-6AAE-4A97-A55D-2C0DBC7F45D2Q47938544-BFA59C5B-2854-4016-B0A5-E137B55ADEC9Q51325614-36CD1CB2-56E4-4900-B959-031B1D008180Q51351954-EFC7CF0D-B6E3-411B-9512-94F4AB5EA698Q52851661-2ED93AFB-F9A5-40C7-9F9B-B231E15DF32FQ55240881-9BBD95D1-65B6-47B9-B258-4E212DD85D46
P2860
Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
@en
Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
@nl
type
label
Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
@en
Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
@nl
prefLabel
Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
@en
Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
@nl
P2093
P2860
P356
P1476
Osteoblast differentiation is functionally associated with decreased AMP kinase activity
@en
P2093
Eiichi Nagaoka
Hiraku Suzuki
Kyoko Kakimoto
Norika Chiba
Shin-ichiro Kawamoto
Takayuki Kasai
Tetsuya Matsuguchi
Tomokazu Ohnishi
P2860
P304
P356
10.1002/JCP.21917
P577
2009-12-01T00:00:00Z